C1 and N5 derivatives of cerpegin: Synthesis of a new series based on structure–activity relationships to optimize their inhibitory effect on 20S proteasome
Authors:
- Anna HovhannisyanAHAnna Hovhannisyan
- The Hien PhamTPThe Hien Pham
- Dominique BouvierDBDominique Bouvier
- Lixian QinLQLixian Qin
- Gagik MelikyanGMGagik Melikyan
- Michèle Reboud-RavauxMRMichèle Reboud-Ravaux
- Michelle Bouvier-DurandMBMichelle Bouvier-Durand
- 1 May 2013
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 23 (9) , 2696-2703
Abstract
No abstract availableKeywords
Funding Information
- French Association against Myopathies
This publication has 33 references indexed in Scilit:
- Covalent and non-covalent reversible proteasome inhibitionBiological Chemistry, 2012
- Noncovalent inhibition of 20S proteasome by pegylated dimerized inhibitorsEuropean Journal of Medicinal Chemistry, 2012
- Proteasome Inhibitors: An Expanding Army Attacking a Unique TargetChemistry & Biology, 2012
- Reorganizing the protein space at the Universal Protein Resource (UniProt)Nucleic Acids Research, 2011
- The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradationNature Reviews Molecular Cell Biology, 2011
- Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunitBiochemical Journal, 2010
- Proteasome Inhibitors in Cancer Therapy: Lessons from the First DecadeClinical Cancer Research, 2008
- The Protein Data BankNucleic Acids Research, 2000
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973